Literature DB >> 1266841

Prognostic value of spontaneous hyponatremia in cirrhosis with ascites.

V Arroyo, J Rodés, M A Gutiérrez-Lizárraga, L Revert.   

Abstract

Spontaneous hyponatremia in cirrhosis with ascites is generally considered to be due to an impaired renal ability to excrete free water, to be a contraindication of diuretics, and to be a bad prognostic sign. These concepts are reviewed in this paper. 55 cirrhotics with ascites were divided into three groups. Group I consisted of 13 patients with hyponatremia and very low free-water clearance CH2O, 0.07 +/- 0.26 ml/min). These patients also had poor renal function: low inulin clearance (CINU, 40.6 +/- 25.9 ml/min) and paraaminohippurate clearance (CPAH, 383 +/- 275 ml/min). Group II consisted of 8 patients who also had hyponatremia. CH2O, CINU, and CPAH in these patients were fairly high: 5.85 +/- 1.53 ml/min, 85.7 +/- 26.2 ml/min, and 651 +/- 294 ml/min. These values are similar to those o7 +/- 4.27 ml/min, 94.7 +/- 33.1 ml/min, and 598 +/- 199 ml/min. Hyponatremia in Group I could be related to the impaired free-water clearance. The mechanism of hyponatremia in Group II patients is not clear. Patients with hyponatremia and low CINU and CPAH had a negative response to diuretics and a poor prognosis. Patients with hyponatremia but with relatively good renal function had a good prognosis, similar to Group III patients. They responded to diuretics with no worsening of their hyponatremia.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1266841     DOI: 10.1007/BF01095898

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  21 in total

1.  THE KIDNEY IN CIRRHOSIS. II. DISORDERS OF RENAL FUNCTION.

Authors:  W P BALDUS; R N FEICHTER; W H SUMMERSKILL; J C HUNT; K G WAKIM
Journal:  Ann Intern Med       Date:  1964-03       Impact factor: 25.391

2.  Renal failure in Laennec's cirrhosis. III. Diuretic response to administered water.

Authors:  R G LANCESTREMERE; P L DAVIDSON; L E EARLEY; F J O'BRIEN; S PAPPER
Journal:  J Lab Clin Med       Date:  1962-12

3.  An explanation for and experimental correction of the abnormal water diuresis in cirrhosis.

Authors:  H P SCHEDL; F C BARTTER
Journal:  J Clin Invest       Date:  1960-02       Impact factor: 14.808

4.  Paradoxical hyponatremia associated with congestive heart failure and with cirrhosis of the liver.

Authors:  P J TALSO; N SPAFFORD; G FERENZI; H O JACKSON
Journal:  Metabolism       Date:  1956-01       Impact factor: 8.694

5.  A new method for the determination of inulin in plasma and urine.

Authors:  A HEYROVSKY
Journal:  Clin Chim Acta       Date:  1956 Sep-Oct       Impact factor: 3.786

6.  Studies in edema. IV. Water retention and the antidiuretic hormone in hepatic and cardiac disease.

Authors:  A G WHITE; G RUBIN; L LEITER
Journal:  J Clin Invest       Date:  1953-10       Impact factor: 14.808

7.  FACTORS INFLUENCING ASCITES IN PATIENTS WITH CIRRHOSIS OF THE LIVER.

Authors:  E P Ralli; J S Robson; D Clarke; C L Hoagland
Journal:  J Clin Invest       Date:  1945-05       Impact factor: 14.808

8.  The effects of pitressin on the metabolism and excretion of water and electrolytes in normal subjects and patients with cirrhosis and ascites.

Authors:  W P IH NELSON; L G WELT
Journal:  J Clin Invest       Date:  1952-04       Impact factor: 14.808

9.  Complications of diuretic therapy in hepatic cirrhosis.

Authors:  S Sherlock; B Senewiratne; A Scott; J G Walker
Journal:  Lancet       Date:  1966-05-14       Impact factor: 79.321

10.  [Water-electrolyte disorders in hepatic cirrhosis with ascites].

Authors:  V Arroyo; J Rodes; J M Sánchez-Tapias; J M Bordas; J Teres; M Brugera; M A Gassull
Journal:  Rev Clin Esp       Date:  1972-03-15       Impact factor: 1.556

View more
  37 in total

Review 1.  Water retention and aquaporins in heart failure, liver disease and pregnancy.

Authors:  R W Schrier; M A Cadnapaphornchai; M Ohara
Journal:  J R Soc Med       Date:  2001-06       Impact factor: 5.344

Review 2.  Kidney Failure and Liver Allocation: Current Practices and Potential Improvements.

Authors:  Varun Saxena; Jennifer C Lai
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

3.  New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt.

Authors:  Jennifer Guy; Ma Somsouk; Stephen Shiboski; Robert Kerlan; John M Inadomi; Scott W Biggins
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-26       Impact factor: 11.382

4.  Transjugular intrahepatic portosystemic shunt in the management of refractory ascites.

Authors:  Guadalupe Garcia-Tsao
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

5.  Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites.

Authors:  P A McCormick; P Mistry; G Kaye; A K Burroughs; N McIntyre
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

6.  Treatment of ascites in patients with cirrhosis of the liver.

Authors:  V Arroyo; P Ginés; J Rodés
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

7.  The prognosis of hyponatremia at hospital admission.

Authors:  W M Tierney; D K Martin; M C Greenlee; R L Zerbe; C J McDonald
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

8.  Cirrhotic ascites review: Pathophysiology, diagnosis and management.

Authors:  Christopher M Moore; David H Van Thiel
Journal:  World J Hepatol       Date:  2013-05-27

9.  Hyponatremia and mortality among patients on the liver-transplant waiting list.

Authors:  W Ray Kim; Scott W Biggins; Walter K Kremers; Russell H Wiesner; Patrick S Kamath; Joanne T Benson; Erick Edwards; Terry M Therneau
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

10.  MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.

Authors:  Maria-Carlota Londoño; Andrés Cárdenas; Mónica Guevara; Llorenç Quintó; Dara de Las Heras; Miguel Navasa; Antoni Rimola; Juan-Carlos Garcia-Valdecasas; Vicente Arroyo; Pere Ginès
Journal:  Gut       Date:  2007-04-23       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.